شهد ضرغام علي القطبي

SUMARY. Background and Purpose: A significant part of the "post-acute COVID-19 syndrome" that may significantly aggravate patients' clinical history is pulmonary fibrosis (PF), a pathological result of chronic and acute interstitial lung illnesses linked to impaired wound repair. Despite being inconclusive, the information that is currently available suggests that more than a third of COVID-19 hospital patients experience aberrant lung fibrosis after leaving the hospital. The current study's goal is to ascertain if pulmonary fibrosis and COVID-19 susceptibility are related. Material and Method: The Al-Amal Hospital provided data on coronavirus infections. Regarding Pulmonary Fibrosis, Age, and Gender in the Najaf Province in 2022. The results were evaluated using the Statistical Analysis System application's Chi-squared test (SPSS). Results: In the study results of our study were as follows, where it was found that (11.21%) of the total patients in the age group 18-25 are prone to sufering from pulmonary fibrosis, while (20%) of the age group were 25-36, and also found that (29.08%, 45.74% and 31.19%) for the following age groups, respectively: 36-47y, 47-57y and 57-67y. Finally, it was found that 117 (26.77%) patients out of 320 suffer from pulmonary fibrosis symptoms of the age group 67-77 years, where it formed a significant difference compared with the rest of the age groups. Conclusion: There is a link between infection with COVID 19 and pulmonary fibrosis, among other conditions. However, our study shows that severe COVID-19 is linked with considerable respiratory symptoms and morbidity, including dyspnea, which was reported by many survivors. There is an urgent need for more research to understand the connection more generally and to identify therapies that might help prevent similar lung infections in the future. RESUMEN. Antecedentes y propósito: una parte significativa del "síndrome post-agudo de COVID-19" que puede agravar significativamente la historia clínica de los pacientes es la fibrosis pulmonar (FP), un resultado patológico de enfermedades pulmonares intersticiales agudas y crónicas relacionadas con reparación deficiente de heridas. . A pesar de no ser concluyente, la información disponible actualmente sugiere que más de un tercio de los pacientes hospitalizados con COVID-19 experimentan una fibrosis pulmonar aberrante después de salir del hospital. El objetivo del estudio actual es determinar si la fibrosis pulmonar y la susceptibilidad a la COVID-19 están relacionadas. Material y Método: El Hospital Al-Amal aportó datos de contagios por coronavirus. Con respecto a la fibrosis pulmonar, la edad y el sexo en la provincia de Najaf en 2022. Los resultados se evaluaron mediante la prueba de chi-cuadrado (SPSS) de la aplicación Statistical Analysis System. Resultados: En el estudio los resultados de nuestro estudio fueron los siguientes, donde se encontró que el (11,21%) del total de pacientes en el grupo de edad 18-25 son propensos a padecer fibrosis pulmonar, mientras que el (20%) del grupo de edad fueron 25-36, y también encontraron que (29,08%, 45,74% y 31,19%) para los siguientes grupos de edad, respectivamente: 36-47y, 47-57y y 57-67y. Finalmente, se encontró que 117 (26,77%) pacientes de 320 padecen síntomas de fibrosis pulmonar del grupo de edad de 67-77 años, donde formó una diferencia significativa en comparación con el resto de los grupos de edad. Conclusión: Existe un vínculo entre la infección por COVID 19 y la fibrosis pulmonar, entre otras condiciones. Sin embargo, nuestro estudio muestra que la COVID-19 grave está relacionada con síntomas respiratorios y morbilidad considerables, incluida la disnea, que informaron muchos sobrevivientes. Existe una necesidad urgente de más investigación para comprender la conexión de manera más general e identificar terapias que puedan ayudar a prevenir infecciones pulmonares similares en el futuro.

SUMARY. Background and Purpose: A significant part of the "post-acute COVID-19 syndrome" that may significantly aggravate patients' clinical history is pulmonary fibrosis (PF), a pathological result of chronic and acute interstitial lung illnesses linked to impaired wound repair. Despite being inconclusive, the information that is currently available suggests that more than a third of COVID-19 hospital patients experience aberrant lung fibrosis after leaving the hospital. The current study's goal is to ascertain if pulmonary fibrosis and COVID-19 susceptibility are related. Material and Method: The Al-Amal Hospital provided data on coronavirus infections. Regarding Pulmonary Fibrosis, Age, and Gender in the Najaf Province in 2022. The results were evaluated using the Statistical Analysis System application's Chi-squared test (SPSS). Results: In the study results of our study were as follows, where it was found that (11.21%) of the total patients in the age group 18-25 are prone to sufering from pulmonary fibrosis, while (20%) of the age group were 25-36, and also found that (29.08%, 45.74% and 31.19%) for the following age groups, respectively: 36-47y, 47-57y and 57-67y. Finally, it was found that 117 (26.77%) patients out of 320 suffer from pulmonary fibrosis symptoms of the age group 67-77 years, where it formed a significant difference compared with the rest of the age groups. Conclusion: There is a link between infection with COVID 19 and pulmonary fibrosis, among other conditions. However, our study shows that severe COVID-19 is linked with considerable respiratory symptoms and morbidity, including dyspnea, which was reported by many survivors. There is an urgent need for more research to understand the connection more generally and to identify therapies that might help prevent similar lung infections in the future. RESUMEN. Antecedentes y propósito: una parte significativa del "síndrome post-agudo de COVID-19" que puede agravar significativamente la historia clínica de los pacientes es la fibrosis pulmonar (FP), un resultado patológico de enfermedades pulmonares intersticiales agudas y crónicas relacionadas con reparación deficiente de heridas. . A pesar de no ser concluyente, la información disponible actualmente sugiere que más de un tercio de los pacientes hospitalizados con COVID-19 experimentan una fibrosis pulmonar aberrante después de salir del hospital. El objetivo del estudio actual es determinar si la fibrosis pulmonar y la susceptibilidad a la COVID-19 están relacionadas. Material y Método: El Hospital Al-Amal aportó datos de contagios por coronavirus. Con respecto a la fibrosis pulmonar, la edad y el sexo en la provincia de Najaf en 2022. Los resultados se evaluaron mediante la prueba de chi-cuadrado (SPSS) de la aplicación Statistical Analysis System. Resultados: En el estudio los resultados de nuestro estudio fueron los siguientes, donde se encontró que el (11,21%) del total de pacientes en el grupo de edad 18-25 son propensos a padecer fibrosis pulmonar, mientras que el (20%) del grupo de edad fueron 25-36, y también encontraron que (29,08%, 45,74% y 31,19%) para los siguientes grupos de edad, respectivamente: 36-47y, 47-57y y 57-67y. Finalmente, se encontró que 117 (26,77%) pacientes de 320 padecen síntomas de fibrosis pulmonar del grupo de edad de 67-77 años, donde formó una diferencia significativa en comparación con el resto de los grupos de edad. Conclusión: Existe un vínculo entre la infección por COVID 19 y la fibrosis pulmonar, entre otras condiciones. Sin embargo, nuestro estudio muestra que la COVID-19 grave está relacionada con síntomas respiratorios y morbilidad considerables, incluida la disnea, que informaron muchos sobrevivientes. Existe una necesidad urgente de más investigación para comprender la conexión de manera más general e identificar terapias que puedan ayudar a prevenir infecciones pulmonares similares en el futuro.

Conclusions The presence of mucosal thickening or mucosal cysts may be due to the presence of irritative stimuli, which are often an infection of dental origin because these findings are more prevalent in dentulous subjects. The accurate diagnosis of infective foci (chronicapical periodontitis and deep pockets caused by periodontitis) is necessary because decreased host resistance may lead to acute sinusitis.

CONCLUSION The knowledge, attitude, and behavior of Iraqi dentists about infection control measures are relatively weak. This situation indicates that cross infection control topics do not elicit interest among dentists, or a deficiency exists in continuing dental education on how to avoid cross infection in dental practices. Further studies should be designed to identify the reasons. Improved compliance with recommended infection control measures is required for all dentists. Continuing education programs and short courses/workshops about cross infection and infection control procedures are important to improve the knowledge, awareness, attitude, and behavior of Iraqi dentists.

Conclusion On the basis of the responses obtained in this study, the KAP level of the participants with regard to radiation protection protocol was highest with the interns and lowest with the third-year students. The principle of radiation protection implies performing tasks that will minimize the exposure of patients and dental professionals while providing the benefits of diagnostic radiography to patients. The level of awareness was distributed (highest among interns, followed by fourth- and third-year students). Nevertheless, findings show that the more the participants were exposed to clinical situations, the more aware they become. Similar studies with reassurance programs at regular intervals should be performed at institutional and national levels for strict adherence of regulation protocols.

Conclusions: Sonographic findings have a high accuracy in differentiating benign from malignant cervical lymph nodes. High resolution color Doppler ultrasound may provide information that is useful in making correct diagnoses